conbercept ophthalmic injection （0.5mg）

DRUG2 trials

Sponsors

Chengdu Kanghong Biotech Co., Ltd., Bojie Hu

Conditions

Polypoid Choroidal Vasculopathy (PCV)Proliferative Diabetic Retinopathy

Phase 4

Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy

Chengdu Kanghong Biotech Co., Ltd.Polypoid Choroidal Vasculopathy (PCV)

Start: 2017-04-25End: 2020-02-28Target: 200Updated: 2017-08-09

Unknown Phase

Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab Injection

CompletedNCT07144865

Bojie HuProliferative Diabetic Retinopathy

Start: 2024-12-01End: 2025-04-01Updated: 2025-08-28